TPDB

3D PDB MODEL

Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

TPDB ID TPDB92054

Peptide_Name

temporin-PEb

Activity

Antibacterial Anticancer Antifungal Toxicity

Activity_category_statistics

Anti-infective peptides Cancer-related peptides Toxicity and safety peptides

Database_Source

AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 Antifungipept CAFPdb

Sequence_Type

standard

Has_Modification No

Description A 23-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.

Modification

C-terminal: Amidation

Sequence

FLPIVAKLLSGLLGRKKRRQRRR-NH2

FASTA

>TPDB92054|Antibacterial;Anticancer;Antifungal;Toxicity|length=23
FLPIVAKLLSGLLGRKKRRQRRR-NH2

Formula C124H225N45O26

Absent Amino Acids NDCEHMTWY

Common Amino Acids R

Mass 2762.44

PI 13.10

Basic Residues 9

Acidic Residues 0

Hydrophobic Residues 9

Net Charge +9

Boman Index 4.67

Hydrophobicity -0.570

Aliphatic Index 118.70

Half Life

Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min

Extinction Coefficient Cystines 0

Absorbance 280nm 0.00

Polar Residues 2

number

1

A

6

R

0

N

0

D

0

C

0

E

1

Q

2

G

0

H

1

I

5

L

3

K

0

M

1

F

1

P

1

S

0

T

0

W

0

Y

1

V

Amino Acid Distribution

A: 1 R: 6 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 2 H: 0 I: 1 L: 5 K: 3 M: 0 F: 1 P: 1 S: 1 T: 0 W: 0 Y: 0 V: 1

Length

23

Formula

C124H225N45O26

Mass

2762.44

PI

13.10

Net Charge

+9

Boman Index

4.67

Hydrophobicity

-0.570

C_terminal_Modification

Amidation

Chirality

L

Linear_or_Cyclic

Linear

N_terminal_Modification

Free

Nature

Antimicrobial and Anticancer

Origin

Synthetic analog of Temporin-PE

Evidence 1 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50 = 3.464 µM

Detail Source Activity Anticancer

Activity Measurement 3.464 µM

Target

Cancer Type Lung Cancer

Cell Line NCI-H-157

Tissue Affected Lung

Assay & Model

Assay MTT assay

Testing Time Not Available

Source & Reference

Database Source CancerPPD 2.0

Source CancerPPD2

Year 2018

Other

Source Activity Label	Source Definition
Anticancer	CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.

Evidence 2 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50 = 3.087 µM

Detail Source Activity Anticancer

Activity Measurement 3.087 µM

Target

Cancer Type Brain Tumor

Cell Line U251-MG

Tissue Affected Brain

Assay & Model

Assay MTT assay

Testing Time Not Available

Source & Reference

Database Source CancerPPD 2.0

Source CancerPPD2

Year 2018

Evidence 3 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50 = 3.051 µM

Detail Source Activity Anticancer

Activity Measurement 3.051 µM

Target

Cancer Type Prostate Cancer

Cell Line PC-3

Tissue Affected Prostate

Assay & Model

Assay MTT assay

Testing Time Not Available

Source & Reference

Database Source CancerPPD 2.0

Source CancerPPD2

Year 2018

Evidence 4 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50 = 3.483 µM

Detail Source Activity Anticancer

Activity Measurement 3.483 µM

Target

Cancer Type Skin Cancer

Cell Line MDA-MB-435S

Tissue Affected Skin

Assay & Model

Assay MTT assay

Testing Time Not Available

Source & Reference

Database Source CancerPPD 2.0

Source CancerPPD2

Year 2018